Ildstad Suzanne's Form 4 filing
Tourmaline Bio, Inc. (TRML) · filed Apr 19, 2023
- Accession no.
- 0001209191-23-024771
- Filed
- Apr 19, 2023
- Trade date
- Apr 17-18, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $319.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ildstad SuzanneCIK 0001845822 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2023 | Common Stock | SSaleDisposed | −99,771 | $2.14 | −$213,509.94 | 2,954,353 | Direct | |
| Apr 18, 2023 | Common Stock | SSaleDisposed | −49,211 | $2.15 | −$105,803.65 | 2,905,142 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.